Table 3.
Early and late AEs
| Number of patients |
||||||
|---|---|---|---|---|---|---|
| Grade (NCI-CTCAE v. 4.0) | 0 | 1 | 2 | 3 | 4-5 | |
| Early AE | ||||||
| Urinary frequency | 22 | 21 | 2 | 0 | 0 | |
| Urinary incontinence | 45 | 0 | 0 | 0 | 0 | |
| Urinary retention/obstruction | 27 | 16 | 2 | 0 | 0 | |
| Urinary tract pain | 38 | 7 | 0 | 0 | 0 | |
| Urinary urgency | 42 | 3 | 0 | 0 | 0 | |
| Rectal mucositis/anal pain | 41 | 4 | 0 | 0 | 0 | |
| Late AE | ||||||
| Hematuria/bladder bleeding | 43 | 2 | 0 | 0 | 0 | |
| Urinary retention/obstruction | 43 | 2 | 0 | 0 | 0 | |
| Urinary urgency | 45 | 0 | 0 | 0 | 0 | |
| Rectal bleeding | 24 | 13 | 8 | 0 | 0 | |
Abbreviations: AE = adverse events; NCI-CTCAE = National Cancer Institute Common Terminology Criteria for Adverse Events.